STOCK TITAN

Bionano Genomics Inc - BNGO STOCK NEWS

Welcome to our dedicated news page for Bionano Genomics (Ticker: BNGO), a resource for investors and traders seeking the latest updates and insights on Bionano Genomics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bionano Genomics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bionano Genomics's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.23%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
none
Rhea-AI Summary
Bionano Genomics announces the release of new kits for its Ionic Purification System, offering potential improvements in quality and yield of nucleic acid extraction from complex biological samples. The system uses isotachophoresis (ITP) to extract, purify, and concentrate nucleic acid without damaging it. The Ionic G2 chemistry includes four new kits that provide up to a potential 4.5-fold increase in nucleic acid yield over the leading column-based system.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Bionano Genomics reports Q1 2023 revenue of $7.4 million, a 30% increase YoY. Installed base of Saphyr systems grows by 47% YoY. Collaboration with NVIDIA expected to improve data processing speed. OEM partner in China obtains reagent registrations. Q1 2023 Symposium sees significant expansion. Q1 2023 gross margin improves to 28% YoY. Q1 2023 operating expense increases to $39.9 million YoY. Bionano plans to reduce cash expenditures by $20 million. Webcast scheduled for May 9, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
earnings
-
Rhea-AI Summary
Bionano Genomics will host a conference call and webcast on May 9, 2023, to report financial results for Q1 2023 and highlight recent corporate progress.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.46%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.46%
Tags
none
Bionano Genomics Inc

Nasdaq:BNGO

BNGO Rankings

BNGO Stock Data

59.62M
54.46M
0.48%
11.37%
9.56%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
US
San Diego

About BNGO

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o